Vlach; Jaromir

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vlach; Jaromir.The latest application filed is for "tlr7/8 antagonists and uses thereof".

Company Profile

3.7.13

Vlach; Jaromir - Westford MA
Vlach; Jaromir - La Roche sur Foron FR
VLACH; Jaromir - Redding CT
Vlach; Jaromir - Annandale NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polypeptides inhibiting CD40L Grant 11,248,055 - Pattyn , et al. February 15, 2	2022-02-15
Tlr7/8 Antagonists And Uses Thereof App 20200316051 - Sherer; Brian A. ; et al.	2020-10-08
Pyrimidine derivatives for the treatment of viral infections Grant 10,780,089 - McGowan , et al. Sept	2020-09-22
Pyrimidine Derivatives For The Treatment Of Viral Infections App 20200061059 - McGowan; David ; et al.	2020-02-27
Methods For The Use Of Galectin 3 Binding Protein Detected In The Urine For Monitoring The Severity And Progression Of Lupus Nep App 20190310250 - OKITSU; Lukas Shinji ; et al.	2019-10-10
Pyrimidine derivatives for the treatment of viral infections Grant 10,420,767 - McGowan , et al. Sept	2019-09-24
Pyrimidine derivatives for the treatment of viral infections Grant 10,272,085 - McGowan , et al.	2019-04-30
Polypeptides Inhibiting Cd40l App 20180355050 - Pattyn; Els ; et al.	2018-12-13
Methods for the Modulation of LGALS3BP to Treat Systemic Lupus Erythematosus App 20180251559 - DEMARTINO; Julie ; et al.	2018-09-06
Pyrimidine Derivatives For The Treatment Of Viral Infections App 20180207155 - McGOWAN; David ; et al.	2018-07-26
Pyrimidine Derivatives For The Treatment Of Viral Infections App 20170239245 - Mc GOWAN; David ; et al.	2017-08-24
Pyrimidine derivatives for the treatment of viral infections Grant 9,422,250 - Mc Gowan , et al. August 23, 2	2016-08-23
Pyrimidine Derivatives For The Treatment Of Viral Infections App 20140045849 - McGowan; David ; et al.	2014-02-13
Combinations Of Hcv Protease Inhibitor(s) And Cyp3a4 Inhibitor(s), And Methods Of Treatment Related Thereto App 20100291034 - RALSTON, II; Robert O ; et al.	2010-11-18
Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists Grant 7,498,409 - Vlach , et al. March 3, 2	2009-03-03
Combinations of HCV protease inhibitor(s) and CYP3A4 inhibitor(s), and methods of treatment related thereto App 20070287664 - Ralston; Robert O. II ; et al.	2007-12-13
Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists App 20060269936 - Vlach; Jaromir ; et al.	2006-11-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.